Concepedia

Salman B. Hosain

SB

Statistics

Publications

9

Citations

454

H-Index

9

Active since

2011

Affiliations

University of Louisiana at Monroe(Current)

Louisiana State University Health Sciences Center Shreveport

Tulane University

National Cancer Institute

Louisiana State University Agricultural Center

Salman B. Hosain is an author at University of Louisiana at Monroe specializing in oncology, molecular oncology, and pharmacology.

Publications per year

2011–2019

9

Publications

9

An N-methyladenosine at the transited codon 273 of p53 pre-mRNA promotes the expression of R273H mutant protein and drug resistance of cancer cells

Mohammad B. Uddin, Kartik R. Roy, Salman B. Hosain et al. · Biochemical Pharmacology · 2018 · 111 citations · Full text

, , +15

Ceramide Glycosylation by Glucosylceramide Synthase Selectively Maintains the Properties of Breast Cancer Stem Cells

Vineet K. Gupta, Kaustubh N. Bhinge, Salman B. Hosain et al. · Journal of Biological Chemistry · 2012 · 76 citations · Full text

, , +16

Atezolizumab potentiates Tcell-mediated cytotoxicity and coordinates with FAK to suppress cell invasion and motility in PD-L1<sup>+</sup>triple negative breast cancer cells

Nishant Mohan, Salman B. Hosain, Jun Zhao et al. · OncoImmunology · 2019 · 72 citations · Full text

, , +17

Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells

Salman B. Hosain, Sachin Khiste, Mohammad B. Uddin et al. · Oncotarget · 2016 · 50 citations · Full text

, , +16

The opposite effects of doxorubicin on bone marrow stem cells versus breast cancer stem cells depend on glucosylceramide synthase

Kaustubh N. Bhinge, Vineet K. Gupta, Salman B. Hosain et al. · The International Journal of Biochemistry & Cell Biology · 2012 · 44 citations · Full text

, , +17

1–5 of 9